Viewing Study NCT03215693


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-03 @ 3:02 AM
Study NCT ID: NCT03215693
Status: UNKNOWN
Last Update Posted: 2023-08-16
First Post: 2017-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module